Autos
One man challenges Jerome Lemelson’s patents in court -- even though he seems to have more to lose than to win.
Sept. 4, 2005
Jerome Lemelson’s attorney goes after deep-pocket firms, accusing them of infringing on patents for machine vision.
Aug. 28, 2005
Business
CoCensys Inc. said Thursday that the Parke-Davis division of Warner-Lambert Co. will phase out marketing and patient support programs for the Alzheimer’s drug Cognex, but the companies are negotiating for a replacement product.
June 13, 1997
CoCensys Inc.: The Irvine biopharmaceutical company said Tuesday that it is collaborating with Warner-Lambert Co. and its Parke-Davis division to develop and market drugs to treat central nervous system disorders.
Nov. 1, 1995
Science & Medicine
I have an interest in treatments for Alzheimer’s disease and at the present time in two promising treatments before the Food and Drug Administration.
Nov. 30, 1992
The prognosis for Alzheimer’s patients nowadays is still not good.
May 18, 1994
Quick, what was that prescription your father takes for his ulcer? Zantac? Xanax? Zenate?
Nov. 18, 1994
The Food and Drug Administration on Thursday approved the first drug for the treatment of Alzheimer’s disease, a debilitating brain ailment that robs millions of elderly people of their memory, independence and dignity.
Sept. 10, 1993
Scientists may now have one more weapon in their continuing war against Alzheimer’s disease, an herbal medicine called ginkgo biloba, researchers said Tuesday.
Oct. 22, 1997
Market Overview * Buoyed by further gains in technology stocks, the Nasdaq composite index posted its fourth consecutive record close Tuesday.
Sept. 29, 1993